Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Cabozantinib in Advanced Solid Malignancies

This study has suspended participant recruitment.
(amending to clarify total accrual)
Sponsor:
Information provided by (Responsible Party):
Rebecca Suk Heist, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01588821
First received: April 26, 2012
Last updated: January 5, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)